Biotech In The GCC Is Booming, But Is R&D?

BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens for manufacturing, repackaging, sales, marketing and clinical trials, rather than sites of research and development (R&D) and innovation. However, this may be no bad thing if it appeals to multinationals and encourages further investment. With a business environment designed to attract multinational and domestic firms alike, and free zones to promote trade, the UAE's biotechnology sector is highly likely to become a Middle Eastern leader, ahead of other regional

To read the full article, please choose one of the following options: